Discover 10 Value Picks for Your Portfolio!

Value Radar: 10 New Ideas + Full Valuation Deep‑Dive on Phillips 66 (PSX)

Date: February 26, 2026 (United States)
Market anchor: The U.S. 10‑year Treasury constant‑maturity yield closed near 4.03%–4.09% during February 18–24, 2026; we use 4.06% as the risk‑free rate. Source: Federal Reserve H.15. (federalreserve.gov)


1) Ten fresh, value‑oriented candidates to research now

Screen: durable free cash flow, visible self‑help/cost programs, disciplined balance sheets, and a discount to conservative intrinsic value. All are fresh vs. the prior edition.

  1. RTX (RTX) — strong 2025 results, record backlog, and 2026 guide for $92–$93B sales and $8.25–$8.75B FCF; aero/defense tailwinds continue. (rtx.com)
  2. L3Harris (LHX) — 2025 orders $27.5B; 2026 guide: $23–$23.5B revenue, low‑16% margins, ~$3B FCF; portfolio reshaping underway. (l3harris.com)
  3. U.S. Bancorp (USB) — improving fee lines, positive operating leverage, CET1 10.8%; 2026 set‑up for steadier NIM and normalized credit costs. (usbank.com)
  4. Toyota (TM) — record operating momentum, disciplined pricing, and U.S./China battery investments supporting long‑term competitiveness. (iea.org)
  5. Bayer (BAYRY) — deep value with dividend reset to minimum to accelerate deleveraging; execution and litigation remain key swing factors. (bayer.com)
  6. Restaurant Brands (QSR) — multi‑year algorithm intact (unit growth + comps); U.S. BK remodel cadence flexing but long‑term story consistent. (iea.org)
  7. Valero (VLO) — high‑quality refiner with disciplined capex; trading within a moderate EV/EBITDA band vs. cash generation. (valuesense.io)
  8. Marathon Petroleum (MPC) — robust 2025 results, 2026 capex visibility, and strong capture; sector‑leading returns. (marathonpetroleum.com)
  9. Phillips 66 (PSX) — integrated downstream/NGL platform, large capital returns, clear cost/capture self‑help; today’s deep‑dive. (investor.phillips66.com)
  10. Linde/large‑cap chemicals screen (LIN, DOW, LYB) — for income + operating leverage if 2026‑27 industrial demand improves; watch feedstock spreads. (investor.phillips66.com)

Macro backdrop for energy names: IEA sees 2026 global oil demand growth ~0.93 mb/d while supply could rise ~2.4–2.5 mb/d, implying a comfortable market and range‑bound prices; refinery runs grow but margins have normalized from 2022 peaks. (iea.org)


2) Deep Dive: Phillips 66 (PSX)

2.1 What the business looks like today

  • Segments: Midstream (NGL wellhead‑to‑market), Refining, Marketing & Specialties (M&S), and equity‑accounted Chemicals via CPChem. Integrated logistics and trading link the system. Recent portfolio moves: ceased fuel production at the Los Angeles refinery; acquired the remaining 50% of WRB Refining (full ownership of Wood River and Borger); announced acquisition of the U.K. Lindsey refinery/logistics; sold a majority of German/Austrian retail; continued open season on Western Gateway pipeline. (investor.phillips66.com)
  • 2026 capital budget: $2.37–$2.40B (≈$1.07B sustaining, ≈$1.30B growth). Midstream growth focuses on NGL processing/fractionation/pipelines (Iron Mesa gas plant; Coastal Bend NGL expansion; proposed Corpus fractionator). Refining growth: 100+ low‑cap, high‑return capture projects; Humber gasoline quality project. CPChem (JV) self‑funding ~$680M (PSX share) in 2026 on U.S. Gulf Coast and Qatar projects starting in 2026/early 2027. (investor.phillips66.com)
  • 4Q25 snapshot (adjusted): EBITDA $2.53B; adjusted EPS $2.47; cash from ops (ex‑WC) $2.04B; net debt decreased q/q as proceeds from asset sales funded buybacks/dividends. Year‑end debt ≈$19.7B; cash ≈$1.1B. (investor.phillips66.com)
  • Capital returns: dividend raised to $1.27/quarter (Feb 2026); PSX highlights >$14B returned since mid‑2022 through buybacks + dividends; long history of annual dividend growth since 2012. (investor.phillips66.com)
  • Midstream build‑out: DCP integration beating synergy targets (run‑rate ~$500M); EPIC NGL deal closed in 2025; mgmt presentation indicates Midstream adjusted EBITDA up ~$1.9B vs. 2021 and a pathway toward ~$4.0B post‑EPIC, ~$4.5B by 2027. (investor.phillips66.com)

Why it screens for value right now

  • Self‑help: measurable unit‑cost reductions (Refining controllable costs from $6.98/bbl in 2022 to $5.90/bbl in 2024; target $5.50 by 2027) and multi‑point “market capture” projects. (investor.phillips66.com)
  • Portfolio reshape lowering cyclicality over time (bigger Midstream/NGL and Chemicals contribution; selective divestitures). (investor.phillips66.com)
  • Valuation context: refiner/integrated peers trade on single‑digit EV/EBITDA mid‑cycle; PSX has additional sum‑of‑the‑parts (SOTP) angles given Midstream/Chemicals. (alphaspread.com)

Competitive/industry setting

  • IEA expects adequate crude/product supply in 2026; refining margins have normalized from 2022 highs but benefit from selective capacity closures and North America’s structural advantages; crack spreads likely range‑bound. (iea.org)

2.2 Ground‑up normalization: operating model we’ll value

We build a 5‑year, mid‑cycle view (USD). All assumptions stated and cross‑referenced.

Key modeling inputs (base case)

  • Risk‑free rate: 4.06% (H.15 10‑year, Feb 24–25, 2026 average). Equity risk premium 5.0%–5.5%; beta ~1.1–1.2 for diversified downstream; after‑tax cost of debt ~4.7% (IG ratings A3/BBB+). WACC set at 8.5% (7.5% bull / 9.5% bear). (federalreserve.gov)
  • Shares and net debt: ~403M diluted shares; YE25 debt ≈$19.7B, cash ≈$1.1B → net debt ≈$18.6B. (companiesmarketcap.com)
  • Depreciation & amortization (D&A): ~$2.9–$3.2B run‑rate (TTM quarterly prints ~$0.8B). We model $3.0B. (financecharts.com)
  • Capex: anchored to 2026 plan ($2.37–$2.40B), trending $2.2–$2.6B thereafter as large midstream projects (Coastal Bend, Iron Mesa) roll through. (investor.phillips66.com)
  • Tax rate: 24% effective (long‑term normalized). [Assumption anchored to large‑cap U.S. profiles.]

Segment “mid‑cycle” EBITDA build (our normalization with supporting signposts)

  • Midstream: $4.0–$4.5B by 2027 on DCP + EPIC + organic projects; we use $4.2B mid‑cycle. (investing.com)
  • Refining: $3.5–$4.0B mid‑cycle EBITDA on cost/capture gains, North America advantage, and post‑LA rationalization; we use $3.7B (conservative vs. 2022 peak margin years). (investor.phillips66.com)
  • Marketing & Specialties: $0.8–$1.0B (stable, lower volatility); we use $0.9B. [Assumption based on historical stability and retail rationalization noted in 4Q25.] (investor.phillips66.com)
  • Chemicals (CPChem): equity‑method; distributions historically fund growth; with new U.S. Gulf Coast and Qatar capacity online 2026/27, we assume ~$1.0–$1.2B PSX‑share EBITDA‑equivalent contribution to owner earnings via distributions; we model $1.0B. (investor.phillips66.com)

Implied consolidated mid‑cycle EBITDA: ≈$9.8B (range $9.0–$10.7B). Cross‑check: 4Q25 adjusted EBITDA annualized ≈$10.1B; our mid‑cycle sits just below that “hot quarter ×4.” (investor.phillips66.com)


2.3 FCFF DCF — step‑by‑step (our arithmetic)

We convert normalized EBITDA to free cash flow to the firm (FCFF):

  1. Start with EBITDA: $9.8B
  2. Less D&A ($3.0B) → EBIT ≈ $6.8B
  3. Less tax @24% → NOPAT ≈ $5.17B
  4. Add back D&A: +$3.0B
  5. Less capex: −$2.4B (2026 plan as steady state)
  6. Working capital: assume minimal over cycle (ΔWC ~ $0.1B outflow)

Base‑year FCFF ≈ $5.67B.

Projection logic (2026–2030)

  • EBITDA grows low‑single‑digits (midstream projects ramp, refining capture improves) to ~$10.5B by 2030; D&A drifts to ~$3.1B; capex steadies ~$2.3–$2.6B.
  • Resulting FCFF path (rounded): $5.6B, $5.7B, $5.8B, $5.9B, $6.0B.

Discounting assumptions

  • WACC 8.5% (base), terminal growth g = 1.5% (cyclical, mature).

Valuation math (rounded)

  • PV(FCFF 2026–2030): ≈ $23–$24B
  • PV(Terminal) = FCFF2031/(WACC−g) discounted back: ≈ $52–$53B
  • Enterprise value (EV): ≈ $75–$77B
  • Less net debt (~$18.6B) → equity ≈ $56–$58B
  • Per share (~403M): ≈ $139–$145

Sensitivity (all per‑share, rounded)

  • Bull: WACC 7.5%, g 2.0%, EBITDA ramps to $10.8–$11.0B by 2030, capex toward $2.2B → EV ≈ $88–$96B → equity $69–$77B → $171–$191/sh.
  • Bear: WACC 9.5%, g 1.0%, EBITDA flat $9.0–$9.3B, capex $2.6B → EV ≈ $63–$66B → equity $44–$47B → $109–$117/sh.

Key assumption cross‑checks

  • Risk‑free/WACC parameters from H.15 and IG credit profile. (federalreserve.gov)
  • Capex tied to the 2026 plan and named projects/timelines. (investor.phillips66.com)
  • Midstream EBITDA trajectory and synergy capture from PSX investor materials and DCP/EPIC disclosures. (investor.phillips66.com)
  • Macro margin context (IEA/EIA) to hold refining mid‑cycle below “boom” years. (iea.org)

2.4 Comparable‑multiples cross‑check (SOTP lens)

Market snapshots vary by source/date cut; we triangulate ranges rather than point estimates:

  • Marathon Petroleum (MPC): LTM EV/EBITDA ≈ 8.4× (FactSet/Morningstar composite). (multiples.vc)
  • Valero (VLO): LTM EV/EBITDA ≈ 13× per recent tracker; note high variability with cycle. (valuesense.io)
  • Phillips 66 (PSX): sources show high‑single to low‑teens EV/EBITDA depending on the period; we apply 7.5×–10.5× to normalized EBITDA to avoid boom‑time bias. (alphaspread.com)

Applying 7.5×–10.5× to our mid‑cycle EBITDA range ($9.0–$10.7B):

  • EV ≈ $68–$112B → equity (−$18.6B net debt) ≈ $49–$93B → $121–$231/sh.
  • Narrowing to 8.0×–9.0× on ~$9.5B EBITDA → EV $76–$86B → equity $57–$67B → ~$141–$167/sh.

This band brackets our DCF base ($139–$145) and bull ($171–$191), giving a coherent triangulation.


2.5 Business roadmap and swing factors

Execution levers we like

  • Midstream/NGL scale‑up: Iron Mesa (Q1’27), Coastal Bend expansion (Q4’26), potential Corpus fractionator (FID early 2026) strengthen integrated Gulf Coast optionality and fee‑like cash flows. (investor.phillips66.com)
  • Refining “capture” and cost discipline: >100 small, high‑IRR projects; controllable costs down >$1/bbl since 2022 with a plan to $5.50/bbl by 2027. (investor.phillips66.com)
  • Portfolio pruning: retail exits in EU; Los Angeles shutdown; targeted acquisitions (WRB consolidation; Lindsey U.K.). (investor.phillips66.com)

Key external risks

  • Macro oil/product cycle: IEA projects ample supply and moderate demand growth in 2026; if margins compress below mid‑cycle, Refining EBITDA under‑earns. (iea.org)
  • Policy/regulatory: California market changes and refinery rationalization; low‑carbon policy swings affect renewable credits and project economics. (eia.gov)
  • Activism/strategic alternatives: Elliott has pushed for Midstream separation; outcomes could unlock value or create execution/tax friction. (apnews.com)

What would change our valuation view (up or down)

  • Up: On‑time midstream project start‑ups, sustained refining capture advantage, and CPChem distributions inflecting with 2026–27 projects. (investor.phillips66.com)
  • Down: Prolonged margin trough, cost creep reversing $/bbl gains, or delays/overruns on NGL projects. (investor.phillips66.com)

3) Valuation range and investment take

  • DCF (2/3 weight) + comps (1/3 weight) → blended fair value ≈ $135–$175 per share, with downside support ~$110–$120 and upside case ~$190+.
  • At recent parameters (dividend stepped to $1.27/qtr, capex discipline reiterated) and using ~403M shares and ~$18.6B net debt, PSX screens as a quality value with identifiable self‑help and SOTP optionality.

Suggested action

  • Accumulate on weakness into the $130s (or better) for a margin of safety vs. our $135–$175 intrinsic band. Dividend growth and midstream ramp provide “time as a friend” while capture/cost projects enhance resilience. (investor.phillips66.com)

Why chatter calling PSX “just another cyclical refiner” is off the mark (and where it could still be wrong)

  • Off the mark: The model is increasingly anchored by fee‑like NGL midstream and CPChem distributions, with hard cost/capture proof points and lower capital intensity per dollar of EBITDA. (investor.phillips66.com)
  • Still risks: If 2026–27 stays oversupplied and margins leg materially lower than IEA’s balanced view, or if midstream projects slip, the equity re‑rates toward our bear DCF ($109–$117/sh). (iea.org)

4) Valuation “audit trail” — all key steps documented

  • Risk‑free rate and curve (H.15, Feb 18–25, 2026). (federalreserve.gov)
  • Capital returns and dividend actions (2025 and Feb 2026 increases). (investor.phillips66.com)
  • 2026 capital budget; project list and timing (Iron Mesa Q1’27; Coastal Bend Q4’26; Corpus fractionator FID early ’26; Humber project; 100+ capture projects). (investor.phillips66.com)
  • 4Q25 results (adj. EBITDA, cash from ops ex‑WC, net debt, portfolio actions). (investor.phillips66.com)
  • DCP integration and synergy capture; Midstream EBITDA trajectory; EPIC NGL close. (investor.phillips66.com)
  • Cost discipline and market‑capture progress. (investor.phillips66.com)
  • Macro oil/refining context (IEA; EIA commentary on capacity/margins). (iea.org)
  • Shares outstanding and debt/cash (YE25). (companiesmarketcap.com)
  • Peer multiples (context only; we applied conservative bands). (multiples.vc)
  • Activist backdrop and structural/SOTP debate. (apnews.com)

5) Closing map: why PSX is our “best pick” this edition

Among this week’s 10, PSX offers the cleanest mix of:

  • Visible self‑help (cost/capture) and project‑driven EBITDA growth,
  • A disciplined capital plan with increasing dividend,
  • An integrated NGL + refining + chemicals model that diversifies cash flows,
  • And a valuation that, on our bottom‑up math, leaves mid‑teens to ~40% upside against a well‑bounded downside.

Bottom line: Buy the improving business at a still‑reasonable multiple — and let the midstream/capture flywheel do the compounding.


Disclaimer: This independent analysis is for informational/educational purposes only and is not investment advice. All assumptions are stated and sourced; please do your own research and consider your objectives and risk tolerance.